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Abstract
Background: Few data exist on viral and bacterial etiology of acute lower respiratory infections (ALRI) in ≥5
year –old persons in the tropics.
Methods: We conducted active surveillance of community-acquired ALRI in two hospitals in Cambodia, a
low-income tropical country. Patients were tested for acid-fast bacilli (AFB) by direct sputum examination, other
bacteria by blood and/or sputum cultures, and respiratory viruses using molecular techniques on nasopharyngeal/
throat swabs. Pulmonologists reviewed clinical/laboratory data and interpreted chest X-rays (CXR) to confirm ALRI.
Results: Between April 2007 - December 2009, 1,904 patients aged ≥5 years were admitted with acute pneumonia
(50.4%), lung sequelae-associated ALRI (24.3%), isolated pleural effusions (8.9%) or normal CXR-related ALRI (17.1%);
61 (3.2%) died during hospitalization. The two former diagnoses were predominantly due to bacterial etiologies
while viral detection was more frequent in the two latter diagnoses. AFB-positive accounted for 25.6% of acute
pneumonia. Of the positive cultures (16.8%), abscess-prone Gram-negative bacteria (39.6%) and Haemophilus
influenzae (38.0%) were most frequent, followed by Streptococcus pneumoniae (17.7%). Of the identified viruses, the
three most common viruses included rhinoviruses (49.5%), respiratory syncytial virus (17.7%) and influenza viruses
(12.1%) regardless of the diagnostic groups. Wheezing was associated with viral identification (31.9% vs. 13.8%,
p < 0.001) independent of age and time-to-admission.
Conclusions: High frequency of H. influenzae and S. pneumoniae infections support the need for introduction of
the respective vaccines in the national immunization program. Tuberculosis was frequent in patients with acute
pneumonia, requiring further investigation. The relationship between respiratory viruses and wheezing merits
further studies.
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Background
Pneumonia and other acute lower respiratory infections
(ALRI) are the third leading cause of death worldwide and
the first in low-income countries [1]. The vast majority of
ALRI deaths are due to pneumonia [1] and nearly all
severe ALRI episodes occur in children under 5 years,
the elderly and immuno-compromised individuals (e.g.
HIV-infected). Globally, approximately 4.2 million deaths
caused by ALRI are estimated to occur annually across all
age groups [2]. ALRI is a disease of all ages in low-income
countries; it is one of the most common diagnoses upon
admission [3].
Despite this burden and the development of improved
microbiological molecular methods, only few recent
studies with well characterized ALRI, clinical diagnoses
in which bacterial and viral testing have been addition-
ally performed have been published [4-7]. In general, the
etiology of ALRI, and pneumonia in particular, remains
difficult to establish [8,9] using either insensitive or
non-specific indirect methods such as blood culture,
diagnostic serology and pathogenic detection of the
upper airway [10]. In many low-income countries, most
hospital laboratories do not possess the capacity for mi-
crobiologic diagnostic testing and pneumonia is still
defined clinically using radiographs which are not always
available in many health facilities. Taken together, the
epidemiology of ALRI remains poorly defined across the
developing world.
We collaborated with two Cambodian provincial hospi-
tals to determine the etiology of community-acquired
ALRI. This report summarizes the microbiological, radio-
logical and clinical findings with a focus on patients aged
5 years and older.
Methods
Study site and study population
Cambodia (estimated 2008 population ~14.6 Million)
[11] is a tropical country in Southeast Asia. The country
has very poor health indicators with life expectancy at
birth of 59 years and an infant mortality of 90.9/1,000
live births [11]. The study hospitals were located in
Takeo province (estimated population 0.9 Million) and
Kampong Cham province (estimated pop. 1.7 Million)
[11], both within ~150 km of Phnom Penh, the capital.
Like most Cambodian public hospitals, the selected
study hospitals were ill-equipped with poor laboratory
capacity for microbial identification, possessed no CT
scanners, and had inadequate intensive care units (supple-
mental oxygen available but no mechanical ventilation).
Study design
We enrolled patients aged ≥5 years hospitalized with a
clinical syndrome compatible with ALRI, which was de-
fined as (1) symptom onset ≤14 days AND (2) a fever of
≥38°C or a history of febrile episodes during the last 3
days AND (3) cough, AND at least one of the following
respiratory symptom or signs: dyspnea, chest pain, or
crackles on lung auscultation. Patients with known tu-
berculosis (TB), HIV or active cancer were excluded.
Decision whether to hospitalize was left to the clinicians’
judgment. Demographic information, basic clinical fea-
tures, past medical history and use of antibiotics prior to
admission were collected on a standardized case report
form (CRF). Recorded laboratory and microbiology fin-
dings, antibiotic treatment and outcome status upon
discharge were also collected. Independent expert pul-
monologists unaware of the microbiologic diagnosis
retrospectively interpreted each CXR. They subsequently
assigned the final diagnosis of the various types of ALRI
in this study based on a combination of the CXR inter-
pretation and information from the CRF. Written in-
formed consent was obtained from patients aged 18 years
and older and the parents or guardians of children. The
study was approved by the Cambodian National Ethical
Committee for Medical Research.
Specimen collection
Blood cultures, non-induced sputum samples, and throat
and nasopharyngeal swabs (Tubed Sterile DryswabW
cotton-tip) were to be all collected from each participant
within 48 hours after hospital presentation for direct
examination, culture and molecular diagnostic testing.
Cultures and molecular techniques were performed at
the Institut Pasteur - Cambodia (IPC) in Phnom Penh.
Blood Hemoline Diphasic Performance culture bottles
(BioMérieux) were stored in an incubator at 37°C. The
incubator was provided by the surveillance project and
was transported daily along with sputum which had
been collected in the preceding 12 hours. Swabs were
immediately placed in a viral transport medium after
collection, which was containers consisting of frozen li-
quid nitrogen. As part of the National Tuberculosis
Control Program, direct sputum examination for acid-
fast bacilli (AFB) testing was performed on admission
and repeated during the subsequent two days in the hos-
pital laboratories. White cell counts and blood chemis-
tries were also performed in the hospital laboratories.
The provider-initiated testing and counseling policy was
initiated in 2007 in Cambodia. This policy integrates
routine HIV testing for patients with sexually transmit-
ted infections or TB, pregnant women, and hospitalized
patients suspected of being infected with HIV (per the
National HIV/AIDS program; http://www.nchads.org).
Microbiology testing
All nasopharyngeal and throat samples were tested using
5 validated multiplex reverse transcription polymerase
chain reaction (RT-PCR)/PCR for the presence of 18 viral
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respiratory pathogens including human metapneumovirus,
respiratory syncytial virus (RSV), human bocavirus, Influ-
enza A and B viruses, coronaviruses (OC43, 229E, HKU-1,
NL63, SARS), parainfluenza viruses 1–4, adenoviruses,
rhinovirus and enteroviruses, as previously described else-
where [12,13]. Sputum specimens were stained using the
May-Grünwald-Giemsa method. Only good-quality speci-
mens were submitted for bacterial cultures (defined as
>25 polynuclear leukocytes and <25 squamous epithelial
cells per low-power field) [14]. Sputum specimens were
inoculated on colistin-nalidixic acid agar (CNA), cystine-
lactose-electrolyte-deficient agar (CLED), chocolate poly-
vitex agar with bacitracin, and Ashdown agar. Bacterial
isolates were identified by API gallery (BioMérieux).
Case definitions
A bacteriological diagnosis was confirmed when a patho-
gen was isolated from an uncontaminated blood culture
or sputum specimen obtained on admission. A significant
growth of bacteria was defined as greater than 107 organ-
isms per ml of original sputum. TB infection was defined
by a positive acid-fast-bacilli (AFB) smear, as 97% of them
were linked to a positive culture for Mycobacterium
tuberculosis in Cambodian hospitalized patients (IPC’s un-
published data). Three external expert pulmonologists
concurred that a severe case would be defined by the pres-
ence of at least 2 of the following criteria: systolic blood
pressure <90 mmHg, heart rate ≥120 beats per minute,
respiratory rate ≥30/min, oxygen saturation <90% mea-
sured by pulse oximeter, body temperature <35°C or
≥40°C; international severity indices (e.g. PSI or CURB65)
for pneumonia could not be applied in absence of ICUs
or blood urea testing. Pneumonia was defined by the
radiologic images of lobar consolidation, nodules, alveolar
or interstitial infiltrates; a necrotizing pneumonia meant
presence of cavitations. Preexisting pulmonary lesions may
alter or disguise the appearance of a pneumonic infiltrate.
Consequently we created a separate diagnostic group,
ALRI with lung sequelae which was defined as radiological
images of cavitary sequelae, partial collapse or bronchiec-
tasis. The ALRI with the normal parenchyma group
consisted of patients presenting with symptoms of acute
bronchitis and normal lung radiographs.
Data analysis
We included reliable clinical signs and symptoms, major
laboratory findings, reports of medical history, antibiotic
use during and preceding hospitalization, and the final
diagnosis provided by the pulmonology experts in our ana-
lysis. Statistical differences between various groups were
detected using either Chi-squared or adjusted Chi-squared
test, Chi-squared for trend test, and non-parametric
(Kruskal-Wallis) test as appropriate. Proportions, odds ra-
tios (OR), adjusted ORs (aOR) and p values were calculated
using STATA version 9.0 (Stata corp., College Station, TX,
USA). We used the Mantel-Haenszel test for bivariate ana-
lysis and the Wald test in the logistic regression model
retaining variables with a p value of ≤ 0.1.
Results
Patient characteristics
During April 2007 – December 2009, of 2,193 hospitalized
patients aged ≥5 years who met the eligibility criteria,
1,904 patients were confirmed to have a diagnosis of ALRI
and their data were analyzed (Figure 1). The demographic
characteristics of the patients and their diagnoses are
presented in Table 1.
Microbiological etiology
While nasopharyngeal/throat swabs (97.4%) and blood
samples (89.0%) could be easily obtained for each patient,
sputum samples were only able to be collected in 1,053
patients (12.8% and 54.8% in 5–14 year-olds and >15 year-
olds respectively). Sputum was only available for culture
in 888 (46.6%) patients ranging from 21.9% among cases
presenting with pleural effusions alone to 64.0% among
pneumonia cases. In contrast, sputum specimens were
more readily available for direct AFB examination. This
major gap was mainly explained by incorrect sputum
specimen collection that resulted in salivary contamin-
ation (monthly mean rate 13.2%, range: 5.3% - 23.9%).
Overall, a combination of these tests identified bacterial
and viral etiology in 749 (42.9%) patients ranging from
8.8% positive results in patients with pleural effusions
alone to 69.8% in patients with necrotizing pneumonia
(Table 1). Mixed infections were not associated with sever-
ity (p = 0.192) or a specific type of ALRI, except between
the groups of necrotizing pneumonia and non-cavitary
pneumonia (7.3% versus 1.6%, p < 0.001) (Table 1). Of the
identified pathogens, bacteria (73.9%) were the most fre-
quent etiology in pneumonia with predominantly AFB
(41.2%; 67.7% in necrotizing pneumonia and 21.5% in
non-cavitary pneumonia), followed by Haemophilus
influenzae (9.8%) and Streptococcus pneumoniae (4.5%)
(Figure 2). Bacteria also predominated in lung sequelae-
associated ALRI (67.9%) consisting of H. influenzae
(21.1%), AFB (19.3%), Gram-negative bacteria (11.0%) and
S. pneumoniae (10.6%). In contrast, a viral etiology was
predominant in ALRI patients with a normal CXR (67.5%)
including the pleural effusions group (54.5%) and ALRI
with normal CXR group (74.3%) (Figure 1).
Of the 300 (16.8%) positive sputum or blood cultures,
abscess-prone Gram-negative bacteria (39.6%) (i.e. Klebsiella
pneumoniae, Burkholderia pseudomallei, Pseudomonas aeru-
ginosa) and H. influenzae (38.0%) were most frequent,
followed by S. pneumoniae (17.7%). Of the 305 identified vi-
ruses, the three most common viruses included rhinoviruses
(49.5%), respiratory syncytial virus (17.7%), influenza viruses
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(12.1%) and coronaviruses (10.2%), regardless of the diagnos-
tic groups (Table 1).
Mortality and severity
During hospitalization, 61 (3.2%) patients died, of which
the following etiologic agents were identified in 22 (36.1%)
patients including 7 (31.8%) with Burkholderia pseu-
domallei, 3 with AFB, 3 with various bacteria, 7 with vi-
ruses (including 5 rhinoviruses alone) and 2 with mixed
infections. The median age of the deceased patients was
50 years (range: 6 – 87). When compared to patients who
improved at discharge, those with who died in hospital
were more likely to have B. pseudomallei infection (4.1%
vs. 31.8%, p < 0.001), diagnosis of pneumonia (45.3% vs.
70.5%, p < 0.001), and elevated blood neutrophils count
(34.7% vs. 49.2%, p = 0.024); no differences were observed
in gender, age, with co-morbid conditions, and in combin-
ation with other pathogens.
A total of 188 (9.8%) patients met the criteria for severe
cases, of which the most frequent signs consisted of tachy-
cardia (77.7%), tachypnea (93.1%) and low oxygen satur-
ation (39.4%). Pneumonia with (8.0%) and without (56.4%)
cavitations and ALRI with normal CXR (22.3%) accounted
for the majority of the severe cases. When compared with
non-severe cases, severe cases tended to be younger
(median age 25.5 years vs. 55 years, P < 0.001); 42.6% of
the severe cases were aged 5–15 years and the median age
of severe cases in the non-cavitary pneumonia group was
8 years (Table 1). Other univariate analyses of differences
between severe and non-severe cases are illustrated in
Table 2. Multivariate analyses revealed the following vari-
ables independently associated with severity: <50 years of
age (69.1% vs. 39.8%; adjusted OR (aOR) 2.9, p < 0.001), ele-
vated blood neutrophil count (56.4% vs. 32.9%; aOR 2.0,
p = 0.001), non-cavitary pneumonia (56.4% vs. 32.9%; aOR
3.6, p < 0.001), mortality (9.0% vs. 2.6%; aOR 3.2, p = 0.002),
shorter (<5 days) time to admission (62.8%, aOR 2.0, p =
0.005) and wheezing (33.5% vs. 11.5%, aOR 2.5, p < 0.001)
(Table 3).
Overall, 261 (13.7%) patients presented with wheezing
on admission of which 63 (24.1%) were classified as severe
cases. Among the 5–14 year-olds, 63.4% had wheezing
compared with 11.1% in the >50 year age group. The
frequency of wheezing was significantly higher in acute
bronchitis (32.8%) compared with other diagnostic groups.
Other independent variables that were observed with
wheezing included having an elevated-neutrophil-count
(19.4% vs. 10.7%; aOR 1.8, p = 0.001), being diagnosed with
a rhinovirus infection (32.7% vs. 12.4%; aOR 2.7, p < 0.001)
and being classified as a severe case (33.5% vs. 11.7%; aOR
2.3, p < 0.001). Notably, asthma as a co-morbid condition
was insufficiently recorded in the CRF; only 17 (0.9%)



































Figure 1 Various clinical diagnostic groups among patients aged ≥5 years and hospitalized with acute lower respiratory infection,
Kampong Cham and Takeo provinces, Cambodia, April 2007 – December 2009. *Reasons for exclusion: absence of chest X-ray (11.4%);
patients ascertained as having extra-pulmonary diseases (9.9%) or upper-respiratory infections (0.5%); 8 patients who also had extra-pulmonary
site of infection and those who reported a history of hospitalization within the 2 preceding weeks.
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Table 1 Characteristics of 1904 patients aged ≥5 years hospitalized with community-acquired acute lower respiratory infection from April 2007 to December
2009, Kampong Cham and Takeo provinces, Cambodia
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1904 (%) 959 (50.4) 289 (30.1) 670 (69.9) 169 (8.9) 455 (24.3) 321 (17.1)
Median age in years (IQR*) 53 (38–65) 51 50 52 (35–65) 52 (40–66) 60 (51–70) 44 (17–59) NS NS <0.001 <0.001 <0.001
Mean age in years 50.0 48.6 49.3 48.3 51.0 59.0 40.5 NS NS <0.001 <0.001 <0.001
Age groups in years
5-14 154 (8.1%) 82 (8.6) 0 (0.0) 82 (12.2) 3 (1.8) 1 (0.2) 68 (21.2) <0.001 <0.001 <0.001 <0.001 <0.001
15 - 49 659 (34.6%) 368 (38.4) 144 (49.8) 224 (33.4) 72 (42.6) 97 (21.3) 122 (38.0) <0.001 NS <0.001 NS <0.001
≥50 1091 (57.3) 509 (53.1) 145 (50.2) 364 (54.3) 94 (55.6) 357 (78.5) 131 (40.8) 0.249 NS <0.001 <0.001 <0.001
Gender, male (%) 941 (49.4) 502 (52.3) 157 (54.3) 345 (51.5) 90 (53.3) 205 (45.1) 144 (44.9) NS NS 0.011 0.026 NS
Signs and symptoms on
admission
Wheezing 261 (13.9) 105 (11.1) 13 (4.5) 92 (14.0) 3 (1.8) 50 (11.0) 103 (32.8) <0.001 <0.001 NS <0.001 <0.001
Dry cough 519 (27.3) 229 (23.9) 39 (13.5) 190 (28.4) 111 (65.7) 66 (14.5) 113 (35.2) <0.001 <0.001 <0.001 <0.001 <0.001
Time interval between
presentation and symptoms onset
in days (# of missing values = 112)
Median (IQR) 6 (4–9) 6 (4–9) 7 (4–10) 5 (4–9) 6 (4–10) 6 (4–10) 4 (4–8) <0.001 NS 0.032 0.004 <0.001
Mean 6.3 6.3 7.0 5.9 6. 6 6.7 5.6 <0.002 NS 0.072 0.003 <0.001
Duration of hospital stay in days
Median (IQR) 7 (4–11) 7 (4–10) 6 (4–10) 7 (4–10) 5 (3–8) 9 (6–14) 7 (4–10) NS <0.001 <0.001 NS <0.001
Mean 8.4 7.9 7.8 8 6.5 10.7 7.7 NS <0.001 <0.001 NS <0.001
Reports of medicine use prior to
admission
No antibiotic used 932 (48.9) 455 (47.4) 116 (40.1) 339 (50.6) 103 (60.9) 211 (46.4) 163 (50.8) 0.004 0.002 NS NS NS
Intake of unknown origin 776 (40.8) 405 (42.2) 143 (49.5) 262 (39.1) 43 (25.4) 211 (46.4) 117 (36.4) 0.004 <0.001 NS 0.078 0.013
Antibiotic used 196 (10.3) 99 (10.3) 30 (10.4) 69 (10.3) 23 (13.6) 33 (7.3) 41 (12.8) NS NS 0.087 NS 0.014
Patient outcomes
Deceased 61 (3.2) 43 (4.5) 6 (2.1) 37 (5.5) 5 (3.0) 11 (2.4) 2 (0.6) 0.021 NS 0.076 0.003 NS
Cured or improved 1264 (66.4) 572 (59.6) 117 (40.5) 455 (67.9) 79 (46.7) 321 (70.5) 292 (91.0) <0.001 0.002 <0.001 <0.001 <0.001
Transferred 482 (25.3) 297 (31.0) 154 (53.3) 143 (21.3) 82 (48.5) 89 (19.6) 14 (4.4) <0.001 <0.001 <0.001 <0.001 <0.001



















Table 1 Characteristics of 1904 patients aged ≥5 years hospitalized with community-acquired acute lower respiratory infection from April 2007 to December
2009, Kampong Cham and Takeo provinces, Cambodia (Continued)
Reported co-morbid conditions
Cardiovascular disorder 213 (11.2) 129 (13.5) 9 (3.1) 120 (17.9) 17 (10.1) 28 (6.2) 39 (12.1) <0.001 NS <0.001 NS 0.003
Diabetes mellitus 195 (10.2) 111 (11.6) 32 (11.1) 79 (11.8) 22 (13.0) 40 (8.8) 22 (6.9) NS NS NS 0.023 NS
Renal disorder 136 (7.1) 80 (8.3) 25 (8.7) 55 (8.2) 8 (4.7) 33 (7.3) 15 (4.7) NS NS NS 0.044 NS
Liver disorder 16 (0.8) 10 (1.0) 3 (1.0) 7 (1.0) 3 (1.8) 1 (0.2) 2 (0.6) NS NS NS NS NFS
Severe cases 188 (9.9) 121 (12.6) 15 (5.2) 106 (15.6) 11 (6.5) 14 (3.1) 42 (13.1) <0.001 0.032 <0.001 NS <0.001
Laboratory results**
Leukocytosis (missing values = 12) 663 (34.8) 399 (41.9) 120 (41.7) 279 (42.2) 42(25.3) 133 (29.4) 89 (27.8) NS <0.001 <0.001 <0.001 NS
Elevated neutrophils count
(missing values = 65)
629 (33.0) 378 (40.9) 114 (40.6) 264 (41.1) 40 (24.4) 127 (28.9) 84 (27.0) NS <0.001 <0.001 <0.001 NS
Lymphocytosis
(missing values = 314)
99 (5.2) 46 (5.5) 7 (3.0) 39 (6.4) 8 (5.0) 22 (7.7) 23 (7.5) 0.004 NS NS NS NS
Patients tested by microbiology
method (excluding contaminated
samples or cultures)
Blood culture 1695 (89.0) 862 (89.9) 264 (91.3) 598 (89.3) 149 (88.2) 412 (90.5) 272 (84.7) NS NS NS 0.015 0.012
Sputum culture 888 (46.6) 464 (48.4) 185 (64.0) 279 (41.6) 37 (21.9) 270 (59.3) 117 (36.4) <0.001 <0.001 <0.001 0.002 <0.001
Blood or sputum culture 1789 (94.0) 905 (94.4) 280 (96.9) 625 (93.3) 152 (89.9) 437 (96.0) 295 (91.9) NS NS NS NS 0.016
Sputum smear for acid-fast bacilli
(AFB)
1682 (88.3) 850 (88.6) 280 (96.9) 570 (85.1) 140 (82.8) 434 (95.4) 258 (80.4) NS NS <0.001 0.001 <0.001
Nasopharyngeal/throat swabs by
PCR (a)
1855 (97.4) 935 (97.5) 281 (97.2) 654 (97.6) 164 (97.0) 442 (97.1) 314 (97.8) NS NS NS NS NS
Samples collected for bacterial &
AFB etiologies (b)
1796 (94.3) 911 (95.0) 283 (97.9) 628 (93.7) 152 (89.9) 438 (96.3) 295 (91.9) NS NS NS NS 0.008
Samples collected for bacterial &
viral etiologies (c)
1747 (91.8) 887 (92.5) 275 (95.2) 612 (91.3) 147 (87.0) 425 (93.4) 288 (89.7) NS NS NS NS 0.064
Bacterial or viral yield ‡
Positive blood culture 33 (2.0) 27 (3.1) 5 (1.9) 22 (3.7) 4 (2.7) 2 (0.5) 0 (0.0) NS NS 0.007 0.007 NS
Positive sputum culture 272 (30.6) 138 (29.7) 44 (23.8) 94 (33.7) 8 (21.6) 95 (35.2) 31 (26.5) 0.029 NS NS NS NS
Positive blood or sputum culture
(d)
300 (16.8) 161 (17.8) 47 (16.8) 114 (18.2) 12 (7.9) 96 (22.0) 31 (10.5) NS 0.003 0.079 0.007 <0.001
Positive AFB smear (e) 264 (15.7) 218 (25.7) 153 (54.6) 65 (11.4) 2 (1.4) 42 (9.7) 2 (0.8) <0.001 <0.001 <0.001 <0.001 <0.001



















Table 1 Characteristics of 1904 patients aged ≥5 years hospitalized with community-acquired acute lower respiratory infection from April 2007 to December
2009, Kampong Cham and Takeo provinces, Cambodia (Continued)
Bacterial etiologies†
H. influenzae 114 (38.0) 52 (32.3) 13 (27.7) 39 (34.2) 0 (0.0) 46 (47.9) 16 (51.6) NS 0.005 0.002 NS 0.022
- In sputum 1 114 (41.9) 52 (37.7) 13 (29.5) 39 (41.5) 0 (0.0) 46 (48.4) 16 (51.6)
- In blood 2 1 (3.0) 1 (3.7) 1 (20.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
S. pneumoniae 53 (17.7) 22 (13.7) 6 (12.8) 16 (14.0) 1 (8.3) 23 (24.0) 7 (22.6) NS NS 0.009 NS NS
- In sputum 1 51 (18.8) 20 (14.5) 6 (13.6) 14 (14.9) 1 (12.5) 23 (24.2) 7 (22.6)
- In blood 2 2 (6.0) 2 (7.4) 0 (0.0) 2 (9.1) 0 (0.0) 0 (0.0) 0 (0.0)
B. pseudomallei 28 (9.3) 25 (15.5) 10 (21.3) 15 (13.2) 1 (8.3) 1 (1.0) 1 (3.2) NS NS <0.001 0.020 NS
- In sputum 1 16 (5.9) 14 (10.1) 7 (15.9) 7 (7.4) 1 (12.5) 0 (0.0) 1 (3.2)
- In blood 2 15 (45.5) 14 (51.9) 4 (9.0) 10 (10.6) 0 (0.0) 1 (1.1) 0 (0.0)
K. pneumoniae 43 (14.3) 28 (17.4) 10 (21.3) 18 (15.8) 2 (16.7) 8 (8.3) 5 (16.1) NS NS NS NS NS
- In sputum 1 42 (15.4) 27 (19.6) 10 (22.7) 17 (18.1) 2 (25.0) 8 (8.4) 5 (16.1)
- In blood 2 1 (3.0) 1 (3.7) 0 (0.0) 1 (4.6) 0 (0.0) 0 (0.0) 0 (0.0)
P. aeruginosa 37 (12.3) 19 (11.8) 6 (12.8) 13 (11.4) 1 (8.3) 15 (15.6) 2 (6.5) NS NS NS NS 0.037
S. aureus 11 (3.7) 5 (3.1) 2 (4.3) 3 (2.6) 1 (8.3) 4 (4.2) 1 (3.2) NS NS NS NS NS
Other bacteria 39 (13.0) 22 (13.7) 4 (8.5) 18 (15.8) 7 (58.3) 9 (9.4) 1 (3.2) NS NS NS 0.040 NS
AFB-positive*** 264 (15.7) 218 (25.6) 153 (54.6) 65 (11.4) 2 (1.4) 42 (9.7) 2 (0.8) <0.001 <0.001 <0.001 <0.001 <0.001
Positive PCR results ^
Rhinovirus 151 (49.5) 68 (49.3) 10 (45.5) 58 (50.0) 8 (47.1) 30 (44.1) 45 (54.9) 0.007 NS NS <0.001 0.001
Respiratory syncytial virus 54 (17.7) 23 (16.7) 5 (23.7) 18 (15.5) 5 (29.4) 11 (16.2) 15 (18.3) NS NS NS 0.064 NS
Influenza viruses 37 (12.1) 16 (11.6) 3 (13.6) 13 (11.2) 0 (0.0) 11 (16.2) 10 (12.2) NS NS NS NS NS
Coronaviruses 31 (10.2) 18 (13.0) 2 (9.9) 16 (13.8) 1 (5.9) 11 (16.2) 1 (1.2) NS NS NS 0.080 0.001
Human metapneumovirus 14 (4.6) 7 (5.1) 0 (0.0) 7 (6.0) 2 (11.8) 2 (2.9) 3 (3.7) NS NS NS NS NS
Other viruses 20 (6.6) 6 (4.3) 2 (9.1) 4 (3.5) 2 (11.8) 5 (7.4) 7 (8.5) NS NS NS NS NS
Mixed infections
>1 pathogen (AFB, bact. or virus)
(% = n*100/d)
63 (21.0) 35 (21.7) 16 (34.0) 19 (16.7) 2 (16.7) 22 (22.9) 4 (12.9) NS NS NS NS NS
>1 bacterium identified (% =
n*100/d)
24 (8.0) 12 (7.5) 4 (8.5) 8 (7.0) 0 (0.0) 10 (10.4) 2 (6.5) NS NS NS NS NS
AFB and ≥1 bacterium identified
(% = n*100/d)
30 (10.0) 24 (14.9) 16 (34.0) 8 (7.0) 0 (0.0) 6 (6.3) 0 (0.0) NS NS NS NS NS
AFB & virus (% = n*100/f) 26 (8.5) 18 (13.0) 14 (63.6) 4 (3.5) 0 (0.0) 8 (11.8) 0 (0.0) 0.005 NS NS NS NS



















Table 1 Characteristics of 1904 patients aged ≥5 years hospitalized with community-acquired acute lower respiratory infection from April 2007 to December
2009, Kampong Cham and Takeo provinces, Cambodia (Continued)
Overall etiology results
Bacterial etiologies incl. AFB (% =
n*100/b)
520 (29.0) 355 (39.0) 184 (65.0) 171 (27.2) 0 (0.0) 132 (30.1) 33 (11.2) <0.001 <0.001 0.002 <0.001 <0.001
Viral detection (% = n*100/a) 298 (16.1) 135 (14.4) 21 (7.5) 114 (17.4) 13 (7.9) 68 (15.4) 82 (26.1) NS 0.033 NS <0.001 NS
Identified etiologies (% = n*100/c) 749 (42.9) 449 (50.6) 192 (69.8) 257 (42.0) 13 (8.8) 178 (41.9) 109 (37.8) <0.001 <0.001 0.004 <0.001 <0.001
IQR: interquartile range; NS, not significant (NS is displayed when p value is >10%); PCR, polymerase chain reaction;
ALRI = acute lower respiratory infection; Other viruses include Parainfluenza viruses, Bocaviruses, Adenoviruses.
**Hyperleukocytosis: Leukocytes count ≥11 for 5–10 year-olds or ≥10 for ≥11 year-olds.
**Elevated neutrophils count ≥6 for 5–10 year-olds or ≥7.5 for ≥11 year-olds.
*** % = proportion of AFB-positive by # of patients tested for AFB.
‡ %= proportion of positive results by # of patients tested.
† %= proportion of positive bacteria by # of patients tested positive by sputum or blood culture.
1 and 2 % = proportion of positive bacteria by # of patients tested positive by sputum and blood culture respectively.



















Factors associated with identification of microorganisms
Age was significantly associated with microbiological
yield. The proportion of patients with identifiable viruses
among those presenting with pneumonia (Chi-squared
test for trend 76.3, p < 0.001) or those with ALRI and
normal CXR (Chi-squared test for trend 16.5, p < 0.001)
decreased with increasing age while proportions of pa-
tients with identified bacteria were higher among the
≥10 year-olds compared with that of the <10 year-olds
(17.6% versus 4.3% respectively, p = 0.002). Most patients
(51.1%) reported use of antibiotics (10.3%) or unknown
drugs (40.8%) prior to hospital admission. No associa-
tions were observed between pre-admission antibiotic
use and negative sputum (p = 0.854) or blood (p = 0.275)
culture. When considering the influence of other factors
for virus identification in a multivariate analysis, wheez-
ing (31.9% vs. 13.8%, aOR 2.2, p < 0.001), 5–14 year-old
children (54.6% vs. 14.0%; aOR 1.6, p = 0.001) and short
(<5 days) time to admission (22.6% vs. 11.5%; aOR 1.9,
p < 0.001) had a positive association with viral yield. Of
all detected viruses, only rhinovirus was associated with
wheezing (32.7% vs. 12.3%, aOR 2.7, p < 0001), adjusting
for age.
Interestingly, of the 796 patients whose blood and spu-
tum specimens were negative for bacteria, 121 (15.2%)
patients presented with an elevated blood lymphocyte
count or normal neutrophil count on admission; these
121 patients had no radiographic images indicative of
TB, no necrotizing pneumonia, and no use of antibiotics
preceding hospitalization. The median age was 55 years
(range 6 – 85) and 50.4% were males. Viral etiology was
assigned to 28 (21.6%) patients including rhinoviruses
(35.7%), RSV (42.9%), influenza viruses (14.3%) and para-
influenza viruses (7.1%). Of these, 9 were diagnosed as
having pneumonia (i.e. 4 rhinoviruses, 3 influenza vi-
ruses and 2 RSV), 10 had lung sequelae-associated ALRI
(i.e. 5 RSV, 3 rhinoviruses, 1 influenza virus, 1 parainflu-
enza virus), 2 had pleural effusions alone (i.e. 2 RSV)
and 7 had acute bronchitis (i.e. 1 parainfluenza virus, 3
RSV and 3 rhinoviruses). Of the 5 (3.7%) reported de-
ceased, only one virus (RSV) was identified in a 53 year-
old male presenting with severe non-cavitary pneumonia
and no reported co-morbid conditions.
Discussion
This study is notable in many ways. To our knowledge, it
is the first report of a comprehensive picture of radio-
graphically confirmed pneumonia and other ALRI that
resulted in hospitalization in a low-income tropical coun-
try of Southeast Asia. In addition, only a few studies have
been conducted in semi-rural hospitals in a population of
all ages using a wide range of diagnostic tools to identify
viruses and bacteria causing ALRI [5-7,15,16].
The primary finding relates to categorizing various forms
of ALRI based on radiographic patterns combined with the
identification of pathogens. Indeed, bacterial etiologies var-
ied significantly from one form of ALRI to another. Pneu-
monia, which is mainly caused by bacteria in hospitalized
persons aged ≥5 years, accounted for most of the ALRI
cases. However, a large proportion of the ALRI patients
had radiographic imaging of lung sequelae, most probably
caused by tuberculosis or undertreated pneumonia.
Depending on the immune response of the host, TB



























































H. influenzae S. pneumoniae
Abcess-associated bacteria Other bacteria
Tuberculosis Viruses
*
Figure 2 Etiology of community-acquired acute lower respiratory infection in ≥5 year-old patients hospitalized during
April 2007 – December 2009, Kampong Cham and Takeo provinces, Cambodia (749 patients with positive findings). *Abcess-associated
bacteria include K. pneumoniae, B. pseudomallei, P. aeruginosa, S. aureus.
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Table 2 Univariate analyses: factors associated with severity among ≥5 year-old patients hospitalized with community-
acquired acute lower respiratory infection, April 2007 - December 2009, Kampong Cham and Takeo provinces,
Cambodia (N = 1,904)
Severe cases Non-severe cases p values
Total numbers (N = 1904) 188 9.9% 1716 90.1%
Median age in years (range) 25.5 8-56 55 41-66 <0.001
Mean age in years 32.1 51.8 <0.001
Age groups in years
5-14 80 42.6% 74 4.3% <0.001
15 - 49 50 26.6% 609 35.5% 0.019
≥50 58 30.9% 1033 60.2% <0.001
Gender, male 106 56.4% 835 48.7% 0.068
Signs and symptoms
Wheezing 63 33.5% 198 11.5% <0.001
Dry cough 84 44.7% 435 25.3% <0.001
Time interval between presentation and symptoms onset in days
Median (IQR) 4 2-7 6 4-9 <0.001
Mean 4.9 6.4 <0.001
Duration of hospital stay in days
Median (IQR) 5 3-7 7 4-11 <0.001
Mean 6.1 8.6 <0.001
Reports of medicine use prior to admission
no antibiotics used 97 51.6% 835 48.7% NS
Unidentified drugs used 62 33.0% 714 41.6% 0.028
Antibiotics used 29 15.4% 154 9.0% 0.007
Patient outcomes
Deceased 17 9.0% 44 2.6% <0.001
Cured or improved 132 70.2% 1132 66.0% NS
Transferred 32 17.0% 450 26.2% 0.008
Escaped 7 3.7% 90 5.2% NS
Co-morbidities
Cardiovascular disorder 28 14.9% 190 11.1% NS
Diabetes mellitus 20 10.6% 175 10.2% NS
Renal disorder 18 9.6% 113 6.6% NS
Liver disorder 0 0.0% 16 0.9% NS
Laboratory results
Leukocytosis 106 57.3% 552 32.3% <0.001
Neutrocytosis 106 58.6% 523 34.0% <0.001
Lymphocytosis 14 8.5% 85 5.6% NS
Patients tested by microbiology method
Blood culture 168 89.4% 1527 89.0% NS
Sputum culture 47 25.0% 843 49.1% 0.002
Blood or sputum culture 173 92.0% 1616 94.2% NS
Sputum smear for acid-fast bacilli (AFB) 113 60.1% 1569 91.4% <0.001
Nasopharyngeal swabs 184 97.9% 1671 97.4% NS
Samples collected for bacterial & AFB etiologies 173 92.0% 1623 94.6% NS
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symptoms [17,18]. However, in this study, we were sur-
prised to have found AFB to be the most common patho-
gen in hospitalized patients with acute pneumonia.
Although Cambodia is known as one of the countries with
the highest TB prevalence and incidence reported in the
world (http://www.who.int/tb/country/en/index.html), the
interpretation of these results is unclear. It is possible that
the history of illness was poorly recalled by the patient or
a mixed infection existed with a non-TB respiratory
pathogen which may have led to hospitalization. On the
other hand, there is emerging evidence across the world
and particularly shown in African studies, that M.
tuberculosis is commonly present in acute community-
acquired pneumonia in children [15,19] and adults [20],
particularly in settings of high TB prevalence. One sug-
gested explanation is the increased susceptibility to bacter-
ial infection (particularly pneumococcal infection) by
prior M. tuberculosis infection as demonstrated by experi-
mental studies [21]. In the present study, 21% of tubercu-
losis cases were co-infected with other bacteria, of which
S. pneumoniae was the main (43%) pathogen identified.
Our findings imply that expanding the TB screening cri-
teria to include acute pneumonia might be considered. Of
note, Cambodia is planning to develop a multi-symptoms
Table 2 Univariate analyses: factors associated with severity among ≥5 year-old patients hospitalized with community-
acquired acute lower respiratory infection, April 2007 - December 2009, Kampong Cham and Takeo provinces,
Cambodia (N = 1,904) (Continued)
Samples collected for bacterial & viral etiologies 169 89.9% 1579 92.0% NS
Bacterial or viral yield
Positive blood culture 9 5.4% 24 1.6% 0.002
Positive sputum culture 15 31.9% 257 30.5% NS
Positive blood or sputum culture 24 13.9% 276 17.1% NS
Positive smear for AFB 13 11.5% 251 16.0% <0.001
Positive PCR for viruses 55 29.9% 250 15.0% <0.001
Bacterial etiologies
H. influenzae 5 2.9% 109 6.7% 0.074
S. pneumoniae 3 1.7% 50 3.1% NS
B pseudomallei 5 2.9% 23 1.4% NS
Klebsiella pneumoniae 5 2.9% 38 2.4% NS
P. aeroginosa 1 0.6% 36 2.2% NS
S. aureus 1 0.6% 10 0.6% NS
AFB 13 7.5% 251 15.5% 0.030
Viral etiologies
Rhinovirus 32 17.4% 119 7.1% <0.001
Respiratory syncytial virus 6 3.3% 48 2.9% NS
Influenza viruses 4 2.2% 33 2.0% NS
Coronaviruses 6 3.3% 25 1.5% NS
Human metapneumovirus 4 2.2% 10 0.6% 0.054
Other viruses 5 2.7% 21 1.3% NS
Mixed infections (% = # of the positive results)
>1 pathogen (AFB, bacterium or virus) 3 3.5% 60 8.9% NS
>1 bacterium identified 1 1.2% 25 3.7% NS
AFB and ≥1 bacterium identified 1 1.2% 29 4.3% NS
Co-infections AFB & virus 0 0.0% 26 3.9% NS
Co-infections virus-virus 2 2.3% 6 0.9% NS
Overall etiology results
Bacterial etiologies (AFB or other bacteria) 36 20.8% 498 30.7% <0.001
Viral and bacterial etiologies 86 50.9% 674 42.7% <0.001
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approach to increase cost-effective routine screening for
TB.
Our second main finding also indicates that a non-
negligible proportion of patients presenting with cavitary lung
imaging suggestive of TB were affected by other abscess-
associated bacteria (e.g. K. pneumoniae, B. pseudomallei, S.
aureus, etc.. . .). Prior to this study, these bacteria tended not
to be recognized by local clinicianswho empirically treated pa-
tients with a penicillin A-based therapy, an antibiotic that
is not effective on some naturally resistant strains of
Gram-negative bacteria such as B. pseudomallei [22,23].
In adult patients with non-cavitary pneumonia, common
pathogens causing community-acquired pneumonia in
West and Far-East Asia include S. pneumoniae, Myco-
plasma pneumoniae, Chlamydia pneumoniae and Legion-
ella pneumoniae [15,16,24-26]. First, atypical pathogens
(i.e. C. pneumoniae and M. pneumoniae) were rarely
detected in our hospitalized patients: of a subgroup of
sputum specimens from a group of 304 randomly selected
study patients, only 3 tested positive by PCR: 2 for
M. pneumoniae and 1 for C. pneumoniae (IPC, unpub-
lished data). This result was also observed elsewhere
[20,27,28] and was consistent with another recent study
of community-acquired pneumonia among immuno-
compromised adults in Cambodia [27]. Secondly, we
found a lower frequency of S. pneumoniae compared with
other bacteria. Because S. pneumoniae is known to be fra-
gile, some related infections might have gone undetected
as cultures were performed at IPC after a certain delay
due to transportation of specimens [29]. The extent of un-
detected S. pneumoniae infection may be suggested by the
following sub-study: of a random sample of 24 ALRI cases
(median 58 years of age, range 18 – 78) for which we also
collected urine samples, three (13%, 95% confidence inter-
val 3% - 32%) patients tested positive for S. pneumoniae
antigen by Binax NOWW rapid immunochromatographic
assay (Scarborough, ME). (IPC, unpublished data). Ac-
counting for this underestimation, one might expect
S. pneumoniae or H. influenzae –related respiratory infec-
tions to reach ~60% of the bacterial etiology of acute
pneumonia. As a Global AllianceVaccine Initiative or GAVI -
eligible country, Cambodia introduced H. influenzae b vac-
cines in 2010 and will probably do so in the near future for
pneumococcal conjugate vaccine.
RSV and influenza viruses have been recognized as the
leading causes of severe ALRI in infants and young
Table 3 Independent risk factors for severe community-acquired acute lower respiratory infection among hospitalized
≥5 year-old patients, from April 2007 to December 2009, Kampong Cham and Takeo provinces, Cambodia
Severe cases Non-severe cases
N = 188 % N = 1716 % Adjusted OR* p value**
Age groups
5 - 49 years 130 69.1% 683 39.8% 2.9 <0.001
>50 years 58 30.9% 1033 60.2% reference
Pneumonia
No cavities 106 56.4% 564 32.9% reference
With cavities 15 8.0% 274 16.0% 0.33 0.029
Pleurisy alone 11 5.9% 158 9.2% 0.51 0.133
Sequelae prior infection 14 7.4% 441 25.7% 0.21 <0.001
ALRI with normal CXR 42 22.3% 279 16.3% 0.52 0.018
Neutrophils
Normal 75 39.9% 1063 61.9% reference
Elevated 106 56.4% 523 30.5% 2.03 0.001
Outcome
Improved 132 70.2% 1132 66.0% reference
Deceased 17 9.0% 44 2.6% 3.20 0.002
Wheezing
No 125 66.5% 1494 87.1% reference
Yes 63 33.5% 198 11.5% 2.50 <0.001
Time to admission
<5 days 118 62.8% 653 38.1% 2.00
≥5 days 65 34.6% 984 57.3% reference 0.005
*Adjusted by viral etiology, bacterial etiology, antibiotics intake prior admission, time to admission and gender.
**By Wald test.
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children [30,31]. These viruses can also cause severe ALRI
in certain at-risk groups. In our study, viral pathogens, es-
pecially rhinoviruses and RSV were not only limited to
these high risk groups but were common in older
children. Moreover, age was determined as a major
confounding factor when identifying risks associated with
viral etiologies. Only time-to-admission was independently
associated with the viral identification rate, a finding that
suggests that viral infections were under-detected in many
bacterial ALRI patients who were admitted late in the
course of illness [32].
The extent to which these viruses cause direct and se-
vere ALRI is difficult to assess in our study, particularly
in absence of a control group. Indeed, certain viruses
were demonstrated to be associated with severe pneu-
monia [33]; however, detection of some respiratory vi-
ruses, especially rhinoviruses, was frequently found in
non-ill or non-respiratory infected control groups when
using highly sensitive molecular diagnostic techniques
[13,33-39]. Interestingly we identified viruses in ALRI
patients with little evidence of associated bacterial infec-
tion. Further virologic analyses would be worthwhile to
determine the factors comparing pneumonia cases with
no evidence of bacterial infection to those associated
with superinfection.
Symptoms associated with severity as defined by the pa-
rameters of the study were highly prevalent in children;
the reasons are unclear or potentially explained by several
factors such as having acute pneumonia and/or underlying
asthma. Interestingly, wheezing was also independently
associated with viral respiratory infection. This relation-
ship between viral infection, asthma (wheezing as its sur-
rogate), and disease severity have been observed more
recently. Indeed, recent studies suggest that respiratory in-
fections caused by rhinoviruses or RSV in infancy can lead
to the development of asthma at an older age [40,41],
which could be exacerbated by viral infections [34,42,43].
Recognizing the high frequency of wheezing in children
with pneumonia (~62%) and its association with hyperleu-
cocytosis in our study, it is possible that asthma could
either directly cause a severe case or lead indirectly to
signs of severity via superinfection and subsequent pneu-
monia. Education programs designed to recognize asthmatic
symptoms, teach management strategies, and encourage the
prevention of asthma should be urgently implemented.
These preceding findings need to be interpreted in light
of some major limitations. First, the rate of bacteria identi-
fication in this study was low compared to other studies
using routine clinical diagnostic techniques [15,27,44].
Approximately 17% of bacterial diagnoses were achieved
through the use of blood or sputum cultures. This rela-
tively low yield contrasted with a much higher proportion
of pneumonia-related patients (~40%) who had an
elevated blood neutrophil count, a parameter that is
indicative of bacterial infection. Various factors contrib-
uted to this low yield, including the probable high intake
of antibiotics, which can be bought without a prescription
and frequently are administered irrespective of the proper
dosage and length in Cambodia [45]. Since there was only
a one-time collection of sputum and blood for each pa-
tient, a high bacterial yield was not expected. Moreover,
sputum tests, which are commonly used to diagnose
pneumonia, may lack specificity without evocative clinical
information, have poor sensitivity or are frequently con-
taminated by saliva or upper respiratory tract colonization.
This resulted in having to discard numerous sputum spec-
imens prior to culture in our study. The use of invasive
procedures such as brochioalveolar lavage or sputum in-
duction was difficult to introduce, particularly in children.
Second, the burden of TB in this study was probably largely
underestimated as cultures for M. tuberculosis were not
performed [46].
Conclusions
Overall, introducing a bacteriological laboratory capacity
for ALRI surveillance has proven to be a major invest-
ment in settings of limited resources and experiences,
requiring sustained training and monitoring to ensure
reliability and consistency. Despite these challenges, bac-
teriological testing provides useful insights and contribu-
tions to virologic surveillance [47] and above all, directly
benefits patients' care and treatment.
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